StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)

Close on Nov 17, 2026Market cap $676.84MP/E –Yield –

QuidelOrtho EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

QuidelOrtho's EPS for the twelve months ending Sep 27, 2026 was -$5.41. For fiscal 2025 it was -$16.69. The highest annual figure on record is $18.60 in fiscal 2020.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 28, 2025-$16.69–
FY2024Dec 29, 2024-$30.54–
FY2023Dec 31, 2023-$0.15-101.6%
FY2022Jan 1, 2023$9.56-41.8%
FY2021Jan 2, 2022$16.43-11.7%
FY2020Jan 3, 2021$18.60–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026-$0.78–
Q2 FY2026Jun 28, 2026-$1.36–
Q1 FY2026Mar 29, 2026-$1.35–
Q4 FY2025Dec 28, 2025-$1.92–
Q3 FY2025Sep 28, 2025-$10.78–
Q2 FY2025Jun 29, 2025-$3.77–
Q1 FY2025Mar 30, 2025-$0.19–
Q4 FY2024Dec 29, 2024-$2.64-2740.0%
Q3 FY2024Sep 29, 2024-$0.30–
Q2 FY2024Jun 30, 2024-$2.20–
Q1 FY2024Mar 31, 2024-$25.50-3593.2%
Q4 FY2023Dec 31, 2023$0.10-64.3%
Q3 FY2023Oct 1, 2023-$0.19-152.8%
Q2 FY2023Jul 2, 2023-$0.80-107.1%
Q1 FY2023Apr 2, 2023$0.73-89.0%
Q3 FY2022Oct 2, 2022$0.28-94.5%
Q2 FY2022Jul 3, 2022$0.36-20.0%
Q1 FY2022Apr 3, 2022$11.31–
Q4 FY2021Jan 2, 2022$6.61–
Q3 FY2021Oct 3, 2021$5.08–
Q2 FY2021Jul 4, 2021$0.45–

More QuidelOrtho figures

See a number that looks wrong?